Speaker illustration

Mr Luca Broggini

IRCCS San Donato Polyclinic, San Donato Milanese (Italy)

Nanobodies as novel potential drugs to target cardiac light chain amyloidosis

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Drugs, Drug Targets

Session: Poster Session 2

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb